Discipline: Pharmacology

Technologies 3

• Mechanically-Activated Drug Targeting Nanotechnology
  The Wyss team has developed a novel drug targeting nanotechnology that is activated locally by mechanical forces, either endogenous high shear stresses in blood created by vascular occlusion or mechanical energy applied locally using low-energy ultrasound radiation. Today, vascular blockage is the leading cause of death and disability in United States and Europe. Current therapies...
• Human Organs-on-Chips
  Clinical studies take years to complete and testing a single compound can cost more than $2 billion. Meanwhile, innumerable animal lives are lost, and the process often fails to predict human responses because traditional animal models often do not accurately mimic human pathophysiology. For these reasons, there is a broad need for alternative ways to...
• Microfluidic Hemostasis Monitor
  The body’s ability to stop bleeding, also known as hemostasis, is critical for survival. For patients with blood clotting disorders, medical conditions requiring the use of anticoagulation or antiplatelet drugs, or who require treatment with extracorporeal devices that circulate their blood outside of the body, it is essential that care providers can rapidly monitor their...

News 25

View all

• Press Release A mechanical trigger for toxic tumor therapy
  June 15, 2017
• Press Release Wyss Institute’s Organ Chips get smart and go electric
  June 14, 2017
• Press Release Pulmonary Thrombosis-on-a-Chip provides new avenue for drug development
  May 22, 2017